Endo International Plc (ENDPQ) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ENDPQ Annual Cash Flow →
This page allows investors to follow Endo International Plc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
12 Months
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-2,449.81
Depreciation & amortization306.45
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges2.48
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories22.20
Research and Development in Process0.00
Gain (Loss) on Disposition of Business-10.39
Share-based Compensation11.24
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Common Stock Associated With General And Administrative Expense-
Extinguishment Of Debt Gain Loss Net Of Tax-
Research And Development Asset Acquired Other Than Through Business Combination Written Off-
Debtor Reorganization Items Debt Valuation Adjustments-
Income taxes4.70
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable106.51
Increase (Decrease) in Accounts Payable and Accrued Liabilities1,500.09
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets38.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-2.24
Discontinued operations0.00
Net Cash flow from Operating Activities435.10
Investing Activities
Capital Expenditures-94.33
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Investing Activities-
License Costs-
Payments Of Acquisition Costs And License Fees-
Payments For Product Acquisition Costs And License Fees-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Proceeds from Divestiture of Businesses5.13
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net39.40
Discontinued operations0.00
Net Cash Flow from Investing Activities-49.79
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-6.73
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-5.14
Repayments Of Direct Financing Arrangement Repayments-
Payment On Contingent Consideration-
Proceeds from Issuance of Debt Notes-
Proceeds from Issuance of Debt Loans-
Payments for Repurchase of Convertible Notes-
Adequate Protection Payments-445.52
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-604.63
Effect of exchange rate on cash flow0.70
Discontinued operations0.00
Free Cash Flow340.77
Total Cash Flow-218.62
4 historic quarters locked

Sign in to unlock the full Endo International Plc cash flow history.

About Endo International Plc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001593034-24-000007

Figures are derived from filed reports and may be restated. Historical data is subject to revision.